NxStage Medical Inc (NASDAQ:NXTM)

27.38
Delayed Data
As of May 24
 +0.20 / +0.74%
Today’s Change
21.46
Today|||52-Week Range
29.93
+13.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues96.2M97.3M103.6M107.3M
 
 
 
 
 
Cost of Goods Sold46.7M48.9M50.6M53.3M
 
 
 
 
 
Depreciation And Amortization8.4M8.5M8.4M8.3M
 
 
 
 
 
 
Operating ExpensesGross Income41.1M40.0M44.5M45.7M
 
 
 
 
 
General Expenses43.2M48.9M45.2M47.3M
 
 
 
 
 
Other Operating Expenses98.0K86.0K128.0K72.0K
 
 
 
 
 
Research And Development9.0M11.2M9.9M9.4M
 
 
 
 
 
Total Operating Expenses98.4M106.3M104.3M109.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.2M-9.0M-740.0K-1.7M
 
 
 
 
 
Extraordinary Charge0.000.00-2.0M0.00
 
 
Interest Expense On Debt224.0K168.0K161.0K109.0K
 
 
 
 
 
Other Expenses-200.0K759.0K611.0K259.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.6M-8.4M-2.3M-1.5M
 
 
 
 
 
Income Taxes-22.0K-469.0K-21.0K-264.0K
 
 
 
 
 
Minority Interest-490.0K-32.0K-42.0K-339.0K
 
 
 
 
 
Net Income-2.1M-8.9M-2.3M-1.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS65.8M66.1M66.3M66.4M
 
 
 
 
 
Shares To Calculate EPS Diluted65.8M66.1M66.3M66.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.14-$0.03-$0.02
 
 
 
 
 
EPS Diluted-$0.03-$0.14-$0.03-$0.02